Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan + Amlodipine vs Amlodipine in Hypertension
NCT01103960Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial of telmisartan in hypertension (HTN) (2 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Change From Baseline in Seated Trough Diastolic Blood Pressure at 8 weeks. Started Jul 2010; status: completed.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01103960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01103960.